BioSpace News Archive

Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced the promotion of Dr. Suresh Durgam to the position of Chief Medical Officer.

Dicerna Pharmaceuticals, Inc. announced that the Compensation Committee of the Company’s Board of Directors approved inducement grants of stock options to purchase a total of 288,525 shares of common stock and 65,675 restricted stock units to be distributed among eight new employees with a grant date of Oct. 1, 2020.

TenEleven Group LLC, a leading mental and behavioral health electronic health records (EHR) company, announced a new agreement with Greenwich House to implement their electronic Clinical Record (eCR ™) with Medication Assisted Treatment (MAT).

The Association for Value-Based Cancer Care (AVBCC) is proud to announce a jam-packed agenda for the 2020 Summit. This year’s summit features the who’s who in the cancer care ecosystem in an award winning WEBside chat setting.

MCRA, LLC, a leading medical device and biologics advisory firm and Clinical Research Organization (CRO) integrating U.S. and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, and Quality Assurance, is pleased to announce its role in the successful management and execution of Simplify Medical, Inc.'s clinical study and approval by the U.S. Food and Drug Administration (FDA) of their Premarket Approval (PMA) for the Simplify Disc.

SMSbiotech, a privately held biotech pioneer, has engaged the national investment banking firm, Exemplar Capital, for the purposes of strategic advisory services and capital raising.

C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a biopharmaceutical company pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins through degradation, today announced the pricing of its upsized initial public offering of 9.6 million shares of common stock at a public offering price of $19 per share

Vico Therapeutics, a Leiden, the Netherlands, based biotech company focusing on the development of RNA modulating therapies for rare neurological disorders, today announced the appointment of Rupert Sandbrink, M.D., Ph.D., as the company’s chief medical officer and Anders Hinsby, Ph.D., as independent Director.

BioAesthetics Corporation today announced that it has significantly surpassed its Series A funding goal of $2.5 million, further advancing its inaugural product — the nipple-areolar complex (NAC) graft, or NACgraftTM, for patients who are undergoing breast reconstruction following breast cancer and mastectomy — to clinical use.

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that it will report third quarter 2020 results on Thursday, October 22, 2020, before the market opens